Economic Evaluation of FebriDx®: A Novel Rapid, Point-of-Care Test for Differentiation of Viral versus Bacterial Acute Respiratory Infection in the United States
# Background Acute respiratory infections (ARIs) are commonly treated with antibiotics in outpatient settings, but many infections are caused by viruses and antibiotic treatment is therefore inappropriate. FebriDx®, a rapid point-of-care test that can differentiate viral from bacterial infections, c...
Saved in:
| Main Authors: | Katherine Dick, John Schneider |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Columbia Data Analytics, LLC
2021-09-01
|
| Series: | Journal of Health Economics and Outcomes Research |
| Online Access: | https://doi.org/10.36469/001c.27753 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Utility of the FebriDx point-of-care assay in supporting a triage algorithm for medical admissions with possible COVID-19: an observational cohort study
by: Hamish Houston, et al.
Published: (2021-08-01) -
Negative predictive value of the FebriDx host response point-of-care test in patients presenting to a single Australian emergency department with suspected COVID-19: an observational diagnostic accuracy study
by: Joseph Miller, et al.
Published: (2022-12-01) -
Pontas parietais evocadas ao eletrencefalograma e convulsões febris
by: Lineu Corrêa Fonseca, et al.
Published: (1988-06-01) -
Commentary on oncotype Dx
by: Prashant Mehta, et al.
Published: (2019-01-01) -
Treatment of febrile seizures with intermittent clobazam Tratamento de convuslsões febris com clobazam intermitente
by: Maria Luiza G. Manreza, et al.
Published: (1997-01-01)